Hantz Financial Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.21M | Buy |
109,661
+7,515
| +7% | +$289K | 0.07% | 229 |
|
|
2025
Q1 | $3.96M | Buy |
102,146
+14,730
| +17% | +$571K | 0.07% | 233 |
|
|
2024
Q4 | $2.96M | Buy |
87,416
+7,858
| +10% | +$266K | 0.05% | 278 |
|
|
2024
Q3 | $3.25M | Buy |
79,558
+813
| +1% | +$33.2K | 0.06% | 266 |
|
|
2024
Q2 | $3.03M | Sell |
78,745
-2,746
| -3% | -$106K | 0.06% | 266 |
|
|
2024
Q1 | $3.49M | Buy |
81,491
+463
| +0.6% | +$19.9K | 0.07% | 261 |
|
|
2023
Q4 | $3M | Sell |
81,028
-927
| -1% | -$34.4K | 0.07% | 281 |
|
|
2023
Q3 | $2.97M | Buy |
81,955
+5,021
| +7% | +$182K | 0.08% | 258 |
|
|
2023
Q2 | $2.74M | Buy |
76,934
+2,348
| +3% | +$83.7K | 0.07% | 274 |
|
|
2023
Q1 | $2.65M | Buy |
74,586
+3,340
| +5% | +$119K | 0.07% | 265 |
|
|
2022
Q4 | $2.5M | Buy |
71,246
+4,869
| +7% | +$171K | 0.08% | 262 |
|
|
2022
Q3 | $1.95M | Buy |
66,377
+1,428
| +2% | +$42K | 0.07% | 274 |
|
|
2022
Q2 | $3.53M | Buy |
64,949
+2,810
| +5% | +$153K | 0.12% | 203 |
|
|
2022
Q1 | $3.38M | Buy |
62,139
+7,345
| +13% | +$400K | 0.1% | 222 |
|
|
2021
Q4 | $3.02M | Buy |
54,794
+6,135
| +13% | +$338K | 0.09% | 225 |
|
|
2021
Q3 | $2.32M | Buy |
48,659
+9,234
| +23% | +$441K | 0.08% | 231 |
|
|
2021
Q2 | $1.96M | Buy |
39,425
+12,076
| +44% | +$601K | 0.07% | 240 |
|
|
2021
Q1 | $1.22M | Buy |
27,349
+6,385
| +30% | +$285K | 0.05% | 270 |
|
|
2020
Q4 | $964K | Sell |
20,964
-5,508
| -21% | -$253K | 0.04% | 285 |
|
|
2020
Q3 | $1.25M | Sell |
26,472
-1,202
| -4% | -$56.6K | 0.06% | 238 |
|
|
2020
Q2 | $1.41M | Sell |
27,674
-760
| -3% | -$38.8K | 0.08% | 226 |
|
|
2020
Q1 | $1.35M | Buy |
+28,434
| New | +$1.35M | 0.09% | 211 |
|